Selective Serotonin Reuptake Inhibitors: all 1,366 studies that test it
Page 7 of 14. Open to participants first (105), then studies with results posted, then the rest; newest registration first within each.
- To Evaluate Drug-drug Interactions Between DWN12088 and Nebivolol or Paroxetine in Healthy VolunteersCompletedNCT04888728Phase 1
- Vortioxetine in the Treatment of Depression Associated With Head and Neck Cancers Undergoing RadiotherapyStatus unknownNCT04818099Phase 3
- Myofascial Pain Patients' Response to the Administration of Low Doses of Amitriptyline and Citalopram Compared With the Use of Bite SplintStatus unknownNCT04777838Phase 2/3
- Post-stroke Depression Treatment Effect on Stroke RecurrenceCompletedNCT04776226Not applicable
- Fluoxetine vs CBT in Childhood Anxiety DisordersActive, not recruitingNCT04760275Phase 3
- The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis PatientsWithdrawnNCT04757571Phase 1/2
- Comparing Haloperidol and Olanzapine in Treating Terminal DeliriumStatus unknownNCT04750395Phase 2
- Olanzapine for the Prevention of Postoperative Nausea and VomitingCompletedNCT04718727Phase 1/2
- Fluvoxamine Administration in Moderate SARS-CoV-2 (COVID-19) Infected PatientsCompletedNCT04718480Phase 2
- Fluvoxamine for Adults With Mild to Moderate COVID-19SuspendedNCT04711863Phase 2
- The Safety and Efficacy of Fluoxetine for Refractory Primary Mono-symptomatic Nocturnal Enuresis in ChildrenStatus unknownNCT04676139Phase 3
- Efficacy of Olanzapine, Netupitant and Palonosetron in Controlling Nausea and Vomiting Associated With Highly Emetogenic Chemotherapy in Patients With Breast CancerCompletedNCT04669132Phase 2
- Drug-Drug Interaction Study of HBI-3000 and Paroxetine in Healthy Adult Male and Female SubjectsCompletedNCT04650542Phase 1
- Improving Quality of Life in Early Parkinson's DiseaseStatus unknownNCT04590612Not applicable
- Fluoxetine to Reduce Hospitalization From COVID-19 Infection (FloR COVID-19)WithdrawnNCT04570449Early Phase 1
- Effect of Self-administered tDCS in Patients With MDDCompletedNCT04543123Phase 4
- Optimization of Diagnosis and Treatment of Depression Based on Multidimensional Clinical Assessment ClassificationStatus unknownNCT04528628Not applicable
- Clinical Intervention on Cognitive Impairment of Schizophrenia With Metabolic SyndromeSuspendedNCT04518319Phase 2
- Vortioxetine for Treatment of Depressive Mood and Alcohol UseStatus unknownNCT04498897Phase 2
- Citalopram as a Posterior Cortical Protective Therapy in Parkinson DiseaseCompletedNCT04497168Phase 2
- Efficacy of Online CBT for GAD Compared to Pharmaceutical InterventionsCompletedNCT04478526Not applicable
- A Study to Assess the Effect of Fluvoxamine and Smoking on Pharmacokinetics ( the Movement of Drugs Within the Body) of AZD4635 in Healthy VolunteersCompletedNCT04478513Phase 1
- Effect of Vortioxetine on Cognitive Symptoms in Patients With SchizophreniaStatus unknownNCT04456777Early Phase 1
- Comparison of Vortioxetine and Desvenlafaxine in Adult Patients Suffering From DepressionCompletedNCT04448431Phase 4
- Brain Hippocampal Volume Relationship With Anxious Symptoms in Major Depressive PatientsStatus unknownNCT04430556Not applicable
- Leveraging EEG for Antidepressant Prediction With Sertraline and EscitalopramWithdrawnNCT04388202Phase 4
- Observational Study of Pharmacological Treatment for Premature Ejaculation Concurrent With Erectile DysfunctionStatus unknownNCT04361305Phase 3
- Effects of Serotonin Agonist Citalopram on Multimodal Esophageal Stimulation in Healthy VolunteersCompletedNCT04355455Not applicable
- The Role of Serotonin in Compulsive Behavior in Humans: Underlying Brain MechanismsActive, not recruitingNCT04336228Phase 4
- Vortioxetine in Patients With Depression and Early DementiaCompletedNCT04294654Phase 4
- Open-label, Flexible-dose Study of Vortioxetine in Patients With Depression in IndiaCompletedNCT04288895Phase 4
- Serotonergic Modulation of Cognition, Emotion and Brain Activation in Healthy VolunteersCompletedNCT04239339Phase 4
- Olanzapine for Chemotherapy-induced Nausea and Vomiting ProphylaxisCompletedNCT04232423Phase 3
- Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD)CompletedNCT04220996Phase 4
- Definitive Selection of Neuroimaging Biomarkers for the Diagnosis and Treatment to Common Mental DisordersCompletedNCT04218981Not applicable
- A Study of Individualized Diagnosis and Treatment for Major Depressive Disorder With Atypical FeaturesStatus unknownNCT04209166Not applicable
- Transcutaneous Posterior Tibial Nerve Stimulation for Premature EjaculationCompletedNCT04207723Not applicable
- Endobiotics for Phenotyping of Human Cytochrome P450 EnzymesCompletedNCT04188028Not applicable
- Citalopram and Self Emotional ProcessingStatus unknownNCT04169230Not applicable
- The Effect of Trazodone on the Severity of Obstructive Sleep Apnea in Insomnic Stroke Patients With DepressionCompletedNCT04162743Phase 4
- Canadian Biomarker Integration Network for Depression (CAN-BIND) - Validation StudyCompletedNCT04162522Phase 3
- Citalopram and Stress ReactivityStatus unknownNCT04161209Not applicable
- A Clinical Trial of Fluvoxamine for MelancholiaStatus unknownNCT04160377Phase 2
- The Role of PKC Activation in the Immune-inflammatory Mechanism of Major Depressive DepressionStatus unknownNCT04156425Not applicable
- Study on the Optimal Strategy of Chinese Patients With Bulimia Nervosa After Fluoxetine TreatmentStatus unknownNCT04154813Not applicable
- Brain Response to Serotonergic Medications in ASDStatus unknownNCT04145076Not applicable
- Effects of Single Dose Citalopram and Reboxetine on Urethral and Anal Closure Function on Healthy Female SubjectsCompletedNCT04097288Phase 1
- Evaluation of the Clinical Efficacy and Safety of Dapoxetine, Combined Dapoxetine With Folic Acid and Combined Dapoxetine With Vitamin B12 in Treatment of Patients With Premature EjaculationCompletedNCT04085354Phase 3
- Memory Enhancement by Gamma-hydroxybutyrate vs. Trazodone in Major Depressive Disorder.CompletedNCT04082806Phase 2
- Feasibility of Olanzapine at REduced doSe in hIGHly Emetogenic chemoTherapyCompletedNCT04075955Phase 3
- Vortioxetine for the Treatment of Hoarding DisorderWithdrawnNCT04035850Phase 3
- Effects of Escitalopram on the Sleep EEG Power in Patients With Major Depressive DisorderCompletedNCT04013464Not applicable
- Predicting Treatment Response in Patients With OCDCompletedNCT03993535Phase 4
- Vortioxetine vs Sertraline in MexicansCompletedNCT03978286Phase 4
- Rolapitant Plus Olanzapine in Multiday Cisplatin ChemotherapyWithdrawnNCT03960151Phase 2
- Study to Characterize the Effects of Cytochrome p450 1A2 Inhibition on Systemic Exposure to BMS-986165CompletedNCT03930602Phase 1
- Effects of SERT Inhibition on the Subjective Response to Psilocybin in Healthy SubjectsCompletedNCT03912974Phase 1
- A Clinical Study to Examine the Drug-drug Interactions Between ACT-541468 and Citalopram in Healthy Male and Female SubjectsCompletedNCT03907215Phase 1
- Citalopram Titration in Early Non-responder Patients With Major Depressive DisordersCompletedNCT03899285Phase 2
- Definitive Selection of Neuroimaging Biomarkers in Anxiety Disorder and Obsessive-compulsive Disorder: A Longitudinal Functional Magnetic Resonance Imaging （fMRI） Study With Paroxetine TreatmentCompletedNCT03894085Not applicable
- A Study Investigating Formulations of Vortioxetine Applied Under the Tongue in Healthy SubjectsCompletedNCT03884491Phase 1
- Effect of Tamsulosin on PE Compared With Paroxetine HydrochlorideStatus unknownNCT03879746Phase 3
- Olanzapine Versus Aprepitant Based Antiemetic Regimen for High Emetic ChemotherapyStatus unknownNCT03876938Phase 3
- Study With Vortioxetine on Emotional Functioning in Patients With DepressionCompletedNCT03835715Phase 4
- MBRP + Vortioxetine VS MBRP on Preventing Relapse in Chronic MA UsersStatus unknownNCT03830827Phase 4
- Identification of Multi-modal Bio-markers for Early Diagnosis and Treatment Prediction in Schizophrenia IndividualsStatus unknownNCT03790085Early Phase 1
- Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For SchizophreniaActive, not recruitingNCT03781115Phase 1
- Vortioxetine in the Elderly vs. Selective Serotonin Reuptake Inhibitors (SSRIs): a Pragmatic AssessmentCompletedNCT03779789Phase 4
- Vortioxetine Intravenous Infusion at Initiation of Oral Treatment With Vortioxetine in Patients With DepressionCompletedNCT03766867Phase 2
- Effect of Citalopram on Reflux Episodes in Healthy VolunteersCompletedNCT03746691Phase 4
- Intranasal Insulin and Olanzapine Study in Healthy VolunteersCompletedNCT03741478Phase 1
- Early Predictors of Poor Treatment Response in Patients With Schizophrenia Treated With Atypical AntipsychoticsCompletedNCT03730857Phase 1
- Relative Bioavailability Study of Zoloft Oral Solution to Zoloft TabletsCompletedNCT03711708Phase 4
- Efficacy and Safety of Olanzapine for the Treatment of Nausea and Vomiting in Palliative Cancer CareStatus unknownNCT03679182Phase 2
- National Adaptive Trial for PTSD Related InsomniaCompletedNCT03668041Phase 3
- Antidepressants Trial in Parkinson's DiseaseCompletedNCT03652870Phase 3
- Drug Drug Interaction Study Evaluating the Effect of Fluvoxamine or Fluconazole on PK and Safety of PF-04965842.CompletedNCT03634345Phase 1
- Pre-operative Olanzapine as Prophylactic Antiemetic in Oncologic PatientsCompletedNCT03631004Phase 2/3
- A Prediction Study of Multiple Indexes of the Effect of Different Mechanisms of Antidepressants Treatment on DepressionStatus unknownNCT03623711Early Phase 1
- Vortioxetine add-on Treatment Improves the Symptoms in Patients With Bipolar DepressionStatus unknownNCT03598868Phase 2
- Investigation of the Changes of Brain Structure and Function in Premature Ejaculation Patients and the Effects of Dapoxetine on Central Neural Activity in Premature Ejaculation PatientsStatus unknownNCT03583112Not applicable
- Vortioxetine Monotherapy for Major Depressive Disorder in Type 2 DiabetesWithdrawnNCT03580967Phase 4
- Olanzapine Improves the Chemotherapy Tolerance of Advanced Gastric CancerStatus unknownNCT03575637Phase 2
- Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung CancerStatus unknownNCT03571126Phase 4
- Role of Pentoxifylline as an Adjuvant Therapy for Adult Patients With Major Depressive DisorderCompletedNCT03554447Not applicable
- Biomarkers of Antidepressant Response and Suicidal Events in Depressed YouthCompletedNCT03547219Not applicable
- Anxiety and Depression in Epilepsy: A Pilot Treatment StudyWithdrawnNCT03522987Phase 4
- Accuracy and Efficacy of Trazodone (Desyrel) on Sleep Quality and Pain Management of TMD PatientTerminatedNCT03522207Phase 4
- Effects of Three Single Oral Doses of Trazodone on the QTc Interval Duration in Healthy VolunteersCompletedNCT03516630Phase 1
- Sequential Multiple-Assignment Randomized Trials to Compare Antipsychotic Treatments(SMART-CAT)CompletedNCT03510325Phase 3
- Bioequivalence Study of Paroxetine Tablets and Paxil® Under Fasting and Fed Conditions in Chinese Healthy VolunteersCompletedNCT03504475Phase 1
- Citalopram for Reflux Hypersensitivity and Functional HeartburnStatus unknownNCT03499171Phase 4
- Comparative Efficacy of Duloxetine vs Escitalopram in Patients With FibromyalgiaCompletedNCT03487211Phase 2/3
- Substance Misuse To Psychiatric Disorders for CannabisCompletedNCT03485274Phase 2/3
- Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) ProphylaxisStatus unknownNCT03478605Phase 2
- Cognitive Processing Therapy vs. Sertraline for the Treatment of PTSD & SUD in Egyptian PatientsCompletedNCT03469128Phase 1
- The Effect of G-DBT on the Patients With BN : A Multicenter Randomized Controlled StudyCompletedNCT03455088Not applicable
- Fluoxetine Opens Window to Improve Motor Recovery After StrokeCompletedNCT03448159Phase 2
- OxSYPan: Oxford Study With Young People on AntidepressantsCompletedNCT03436173Not applicable
- Drug-Drug Interaction (DDI) Study for TD-9855CompletedNCT03432793Phase 1